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Abstract
Background: Inhibitory interneurons constitute 30-40% of neurons in laminae I-III and have an important anti-
nociceptive role. However, because of the difficulty in classifying them we know little about their organisation.
Previous studies have identified 3 non-overlapping groups of inhibitory interneuron, which contain neuropeptide Y
(NPY), neuronal nitric oxide synthase (nNOS) or parvalbumin, and have shown that these differ in postsynaptic
targets. Some inhibitory interneurons contain galanin and the first aim of this study was to determine whether
these form a different population from those containing NPY, nNOS or parvalbumin. We also estimated the
proportion of neurons and GABAergic axons that contain galanin in laminae I-III.
Results: Galanin cells were concentrated in laminae I-IIo, with few in laminae IIi-III. Galanin showed minimal co-
localisation with NPY, nNOS or parvalbumin in laminae I-II, but most galanin-containing cells in lamina III were
nNOS-positive. Galanin cells constituted ~7%, 3% and 2% of all neurons in laminae I, II and III, and we estimate
that this corresponds to 26%, 10% and 5% of the GABAergic neurons in these laminae. However, galanin was only
found in ~6% of GABAergic boutons in laminae I-IIo, and ~1% of those in laminae IIi-III.
Conclusions: These results show that galanin, NPY, nNOS and parvalbumin can be used to define four distinct
neurochemical populations of inhibitory interneurons. Together with results of a recent study, they suggest that
the galanin and NPY populations account for around half of the inhibitory interneurons in lamina I and a quarter
of those in lamina II.
Background
Inhibitory interneurons constitute around one third of the
neurons in laminae I-II of rat dorsal horn, and ~40% of
those in lamina III [1]. Immunocytochemical studies sug-
gest that virtually all of these are GABAergic, with some
using glycine as a co-transmitter [1,2]. GABAergic and gly-
cinergic inhibition in the dorsal horn has an important
antinociceptive role [3,4], and its loss is thought to contri-
bute to chronic pain states [5-7]. Sandkuhler [7] has iden-
tified four separate functions for inhibitory interneurons in
this region: (1) regulating the level of activity of nocicep-
tive projection neurons in order to ensure an appropriate
response to noxious stimuli, (2) preventing spontaneous
activity in these cells in the absence of noxious stimuli, (3)
minimising cross-talk between sensory modalities (e.g.
between low-threshold mechanoreceptive and nociceptive
inputs to dorsal horn neurons), and (4) limiting the spatial
spread of activity to somatotopically appropriate regions of
the dorsal horn. It is likely that these different functions
are performed by distinct populations of inhibitory inter-
neurons, each with specific patterns of synaptic input and
output. However, despite their importance, we still know
little about how inhibitory interneurons are organised into
different functional populations, and how these are incor-
porated into the synaptic circuitry of the dorsal horn [8].
There have been many attempts to classify interneur-
ons in this region based on morphological and/or elec-
trophysiological criteria [9-22]. Lamina II has been
extensively studied, and the most widely accepted scheme
is that of Grudt and Perl [16], who identified four main
m o r p h o l o g i c a lc l a s s e s :i s l e t ,c e n t r a l ,v e r t i c a la n dr a d i a l
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these classes account for 70-80% of neurons recorded in
this lamina [11,16,18,19]. It has also been shown that
there is a relationship between morphology and neuro-
transmitter type, since all islet cells are inhibitory, while
radial and most vertical cells are excitatory [17,19,23].
However, those inhibitory neurons that are not islet cells
are morphologically diverse, and include vertical and cen-
tral cells, as well as neurons that cannot be assigned to
any of these classes. Even less is known about functional
populations of interneurons in laminae I and III.
An alternative approach to classifying interneurons is
based on differential expression of neurochemical mar-
kers [24]. For example, certain neuropeptides, such as
neuropeptide Y (NPY) and galanin, are expressed by
inhibitory interneurons, while others (somatostatin, neu-
rotensin, neurokinin B) are found in excitatory cells
[25-30]. In addition, the calcium-binding protein parval-
bumin and the neuronal isoform of nitric oxide synthase
( n N O S )a r ee x p r e s s e db ys o m ei n h i b i t o r yn e u r o n si n
laminae I-III [31-34]. We have previously demonstrated
that among the inhibitory interneurons, NPY, nNOS
and parvalbumin are present in non-overlapping popula-
tions [32]. We have also shown that these differ in their
postsynaptic targets, since axons that contain NPY and
GABA preferentially innervate large projection neurons
in lamina III that express the neurokinin 1 receptor
(NK1r) [35,36], while nNOS-immunoreactive GABAer-
gic axons selectively innervate giant lamina I projection
cells that lack the NK1r [37]. Little is apparently known
about the postsynaptic targets of the axons of parvalbu-
min-containing interneurons, although these are thought
to include the central terminals of low-threshold
mechanoreceptive myelinated primary afferents, with
which they form axoaxonic synapses (DI Hughes and
BA Graham, personal communication).
Galanin is expressed by many peptidergic primary
afferents in the dorsal horn [38,39], but is also present
in some GABAergic neurons in laminae I-III [26]. Gala-
nin-containing cells may therefore form a further popu-
lation of inhibitory interneurons, distinct from those
that contain NPY, nNOS or parvalbumin. The first aim
of this study was to test this hypothesis by looking for
co-localisation of these compounds in neuronal cell
bodies. We went on to provide quantitative data for the
galanin interneuron population, by determining the pro-
portion of neurons and of GABAergic axons in each
lamina that were galanin-immunoreactive.
Methods
Animals
Eight adult male Wistar rats (Harlan, Loughborough,
UK; 230 - 310 g) were deeply anaesthetised with pento-
barbitone and perfused through the left ventricle with
Ringer’s solution followed by 4% freshly depolymerised
formaldehyde. Lumbar spinal cord segments (L2-L4)
w e r er e m o v e d ,s t o r e di nt h es a m ef i x a t i v ef o r5 - 2 4
hours and then cut into 60 μm thick transverse sections
with a vibrating microtome. All experiments were
approved by the Ethical Review Process Applications
Panel of the University of Glasgow, and were performed
in accordance with the European Community directive
86/609/EC and the UK Animals (Scientific Procedures)
Act 1986. All efforts were made to minimize the num-
ber of animals used and their suffering.
For all of the immunocytochemical reactions described
in subsequent sections, incubations in primary and sec-
ondary antibodies were carried out at 4°C. Species-speci-
fic secondary antibodies raised in donkey were obtained
from Jackson Immunoresearch, West Grove, PA, USA
(conjugated to biotin, Rhodamine Red, Cy5 or DyLight
649) or Invitrogen, Paisley, UK (conjugated to Alexa
488). Those conjugated to biotin, Alexa 488 or DyLight
649 were used at 1:500, while those conjugated to Rho-
damine Red or Cy5 were used at 1:100. In all cases,
apart from those that involved tyramide signal amplifica-
tion (TSA), the antibodies were diluted in phosphate
buffered saline that contained 0.3M NaCl but no block-
ing serum. TSA reactions, which were used to ensure
optimal detection of galanin in the cell bodies of neu-
rons, were performed using a tetramethylrhodamine kit
(PerkinElmer Life Sciences, Boston, MA, USA) accord-
ing to the manufacturer’s instructions. The selection of
sections for analysis in each part of the study was made
before immunofluorescence staining was viewed.
Test for co-localisation of galanin with parvalbumin or
nNOS
Sections from the L4 segments of 3 rats were incubated
for 3 days in a mixture of rabbit anti-galanin (Peninsula/
Bachem, St Helens, UK; 1:20,000), affinity-purified gui-
nea pig antibody against parvalbumin [40] (1.08 μg/ml)
and sheep anti-nNOS [41] (1:2,000), and then overnight
in secondary antibodies conjugated to biotin (anti-rabbit
IgG), Cy5 and Alexa 488. The galanin was revealed with
a TSA reaction, as described above. Two sections from
each rat were scanned sequentially (to avoid fluorescent
bleedthrough) with a Bio-Rad Radiance 2100 confocal
microscope, equipped with Argon, green HeNe and red
diode lasers, through a 40× oil-immersion lens. Because
of the limited area covered by the objective lens, it was
necessary to obtain 6 or 7 z-series from each section.
These were scanned at 2 μm z-separation through the
full thickness of the section. Scans were analysed with
Neurolucida for Confocal software (MicroBrightField
Inc, Colchester, VT, USA) and the locations of all gala-
nin- and parvalbumin-containing neurons were drawn
onto an outline of the dorsal horn. Each galanin cell
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noreactive for parvalbumin or nNOS, while the parval-
bumin cells were examined to test whether they were
nNOS-positive.
Test for co-localisation of galanin with NPY
Sections from the L2 segments of 3 rats were incu-
bated for 4 days in rabbit anti-galanin (1:50,000) and
overnight in biotinylated anti-rabbit IgG, followed by
detection with a TSA reaction. They were then incu-
bated for 2 days in rabbit anti-NPY (Bachem; 1:500)
and mouse monoclonal antibody NeuN (Millipore,
Watford, UK; 1:1000), and overnight in secondary anti-
bodies: anti-rabbit IgG conjugated to Alexa 488 and
anti-mouse IgG conjugated to Cy5. Note that although
both galanin and NPY antibodies were raised in rabbit,
the concentration of galanin antibody was too low for
it to be detected by the Alexa 488-labelled secondary
antibody. Two sections from each animal were scanned
with the confocal microscope as described in the pre-
vious section. The scans were analysed with Neurolu-
cida for Confocal and the locations of all neurons that
were immunoreactive for galanin or NPY were indi-
cated on drawings of the dorsal horn. Each of these
neurons was examined to determine whether it showed
one or both types of neuropeptide immunoreactivity.
In order to look for evidence of co-localisation of pep-
tide immunoreactivity in axonal boutons, 100 NPY-
immunoreactive boutons were selected in confocal
scans from a single section for each of the 3 rats. The
selection of boutons was made before the galanin
immunostaining was viewed, and boutons were
sampled throughout the full thickness of laminae I-III.
Each of the selected boutons was then examined to
determine whether it was also galanin-immunoreactive.
Test for co-localisation of NPY and nNOS
We have previously reported that NPY was not co-loca-
lised with reduced nicotinamide adenine dinucleotide
phosphate (NADPH) diaphorase activity (a marker for
nNOS) in laminae I-III [32]. However, it is possible that
the NADPH diaphorase reaction failed to detect some
nNOS-containing neurons, and we therefore tested for
co-localisation of NPY and nNOS. Sections from the L3
segments of 3 rats were incubated for 3 days in rabbit
anti-NPY (1:500) and sheep anti-nNOS (1:1000), and
then overnight in appropriate secondary antibodies con-
jugated to Alexa 488 and Rhodamine Red. Two sections
from each rat were scanned with the confocal micro-
scope and the scans were analysed with Neurolucida for
Confocal as described above. The locations of all NPY-
immunoreactive cells were plotted onto a drawing of
the dorsal horn, and each was then examined to deter-
mine whether it was nNOS-positive.
Proportion of neurons in laminae I-III that contain galanin
Transverse sections from the L3 segments of 3 rats were
incubated for 3 days in a mixture of rabbit anti-galanin
(1:20,000) and NeuN (1:500), and then overnight in sec-
ondary antibodies: anti-mouse IgG conjugated to Cy5
and biotinylated anti-rabbit IgG. Galanin was revealed
with a TSA reaction and the sections were then incu-
bated in Sytox (Invitrogen; 1:50,000) for 30 mins at 20°C
to reveal cell nuclei.
Two sections from each rat were scanned through a
40× oil-immersion lens with the confocal microscope, to
produce sets of z-series that covered the entire cross-
sectional area of laminae I-III, each consisting of 24
optical sections with 1 μm z-spacing. The scans were
analysed with a modification [42] of the optical disector
technique [43-46]. Merged images of NeuN and Sytox-
staining were first viewed with Neurolucida for Confo-
cal. In each z-series, the 14th optical section was desig-
nated as the reference section and the 22nd as the look-
up section. Each optical section in the series was exam-
ined, and the locations of all neuronal nuclei (defined by
the presence of both NeuN-immunoreactivity and
Sytox) that were present in the reference section or
appeared in subsequent sections in the series were
plotted onto an outline of the grey matter. All of those
cells with nuclei that were still present on the look-up
section were then excluded, leaving only neurons for
which the bottom surface of the nucleus was located
between reference and look-up sections. The red chan-
nel (corresponding to galanin immunoreactivity) was
then viewed and the presence or absence of galanin
immunostaining in each of the selected neurons was
determined. Boundaries between laminae I, II and III
were identified from low-magnification scans obtained
with light transmitted through a dark-field condenser
[35,47], while the location of the ventral border of
lamina III was determined from an atlas of rat spinal
cord [48]. Laminar borders were plotted on the draw-
ings, and in this way we were able to determine the pro-
portions of neurons in laminae I, II and III that were
galanin-immunoreactive. Since the number of lamina I
neurons sampled in these sections was relatively small,
we also scanned lamina I from a further 2 sections from
each of the 3 rats. These were analysed in the same
way, except that only cells in lamina I were included.
Although the reference and look-up sections are rela-
tively far apart, we ensured that all neurons with nuclei
that lay between these two planes were included in the
sample by examining every optical section between
them. The positions of reference and look-up sections
within the z-series were arranged so that perikaryal
cytoplasm at both poles of the nucleus was visible in all
cases. This was done to ensure that galanin immunor-
eactivity could be detected even in weakly labelled
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since our aim was to determine the proportion of neu-
rons that were galanin-immunoreactive, rather than the
absolute number of cells in a volume of tissue.
Proportion of GABAergic boutons in laminae I-III that
contain galanin
Antibody against the vesicular GABA transporter
(VGAT) was used to identify GABAergic axons
[35,49-51]. Transverse sections from the L3 segments of
3 rats were incubated for 3 days in a mixture of rabbit
anti-galanin (1:1,000), monoclonal mouse antibody
against VGAT (Synaptic Systems, Göttingen, Germany;
1:1,000) and guinea pig anti-calcitonin gene-related pep-
tide (CGRP; Bachem; 1:10,000), and then overnight in
secondary antibodies conjugated to Alexa 488, Rhoda-
mine Red or Cy5.
Two sections from each of the 3 animals were
scanned sequentially with the confocal microscope
through a 60× oil-immersion lens with a z-separation of
0.3 μm. For each section, a set of 3 or 4 z-series (each
containing at least 24 optical sections) was acquired in
such a way as to cover a vertical strip through the cen-
tral part of laminae I-III.
The scans were analysed with Neurolucida for Confo-
cal. Initially, scans corresponding to VGAT-immunos-
taining were viewed, and those from the same section
were aligned so that the full thickness of laminae I, II
and III within the scanned strip was revealed. The lami-
nar borders (identified as described above) were drawn
onto an overlay, and a 5 × 5 μm grid was placed over
the confocal image stacks. A single optical section (the
10th in the z-series) was viewed and 100 VGAT-immu-
noreactive boutons that were present in this section
were selected from each lamina. This was done by
selecting the VGAT boutons located nearest the bottom
right corners of the grid squares. For each lamina, the
first bouton was obtained from one of the most dorsal
squares, and the selection process then continued with
squares in a dorsal-to-ventral, followed by left-to-right,
direction until 100 boutons had been acquired. Once
the selection was completed, the files corresponding to
galanin immunoreactivity were viewed and the presence
or absence of galanin in each of the selected boutons
was noted. Since this selection method will inevitably be
biased towards boutons that were more extensive in the
z-axis [45], we estimated the z-axis lengths of all of the
selected VGAT-immunoreactive boutons by counting
the number of optical sections (0.3 μmz - s p a c i n g )o n
which they appeared.
Characterisation of antibodies
Details of the primary antibodies used in this study are
g i v e ni nT a b l e1 .W eh a v es h o w nt h a ti m m u n o s t a i n i n g
with the galanin and NPY antibodies in the dorsal horn
can be abolished by pre-incubation with the correspond-
ing peptide [26,28]. It has also been reported that neu-
ronal staining with the galanin antibody is absent in the
brains of galanin knock-out mice [52]. The nNOS anti-
body labels a band of 155 kDa in Western blots of rat
hypothalamus, and immunostaining is abolished by pre-
incubation in nNOS [41]. The parvalbumin antibody
r e c o g n i s e sas i n g l eb a n do f1 3k D ai nb l o t so fm o u s e
brain homogenates [40]. The NeuN antibody was gener-
ated against cell nuclei extracted from mouse brain and
found to react with a protein specific to neurons [53].
We have shown that this antibody apparently labels all
n e u r o n s( a n dn og l i a lc e l l s )i nt h er a ts p i n a lc o r d[ 4 7 ] .
The mouse monoclonal VGAT antibody labels a single
band of 57 kDa in blots of mouse brain and retina, and
immunostaining is blocked by pre-absorption with the
immunising peptide [54]. No staining with this antibody
is seen in Western blots from cultured neurons obtained
from VGAT
-/- mice [55]. The CGRP antibody detects
both a and b forms of the peptide (manufacturer’s
specification).
Results
Distribution of galanin in the dorsal horn
The distribution of galanin-immunoreactivity was simi-
lar to that described in the rat dorsal horn in several
previous studies [38,39,56-61]. Immunoreactive axons
Table 1 Primary antibodies
Antibody Host Antigen Supplier/reference Catalogue number Dilution
Galanin Rabbit polyclonal rat galanin Peninsula/Bachem IHC 7141 (T-4334) 1:20-50,000 (TSA)
1:1,000
nNOS Sheep polyclonal rat nNOS Herbison et al. [41] 1:1,000
Parvalbumin Guinea pig polyclonal mouse parvalbumin Nakamura et al. [40] 1.08 μg/ml
NPY Rabbit polyclonal rat NPY Bachem T-4070 1:500
NeuN Mouse monoclonal Purified cell nuclei from mouse brain Millipore MAB377 1:500-1,000
VGAT Mouse monoclonal Amino acids 75-87 of rat VGAT coupled to KLH Synaptic Systems 131 011 1:1,000
CGRP Guinea pig polyclonal Bachem T-5027 1:10,000
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Page 4 of 13formed a dense plexus in the superficial region, particu-
larly lamina I and the outer half of lamina II (IIo), while
they were also seen at lower density in other laminae
(Figure 1). Scattered immunoreactive cell bodies were
observed, mainly in laminae I and IIo, but occasionally
in the inner half of lamina II (IIi) and in lamina III. The
immunostaining in these cells occupied the perikaryal
cytoplasm, with limited extension into dendritic trees.
Extent of co-localisation of galanin, NPY, nNOS and
parvalbumin
One hundred and seventy four galanin-immunoreactive
cells (48-63 per rat) were identified in the sections reacted
to reveal galanin, parvalbumin and nNOS (Figures 2, 3).
Although galanin-positive cells were found in each of
laminae I-III, they were far more numerous in laminae I
and IIo. Twelve of the cells were located in lamina III, and
these all showed weak galanin immunoreactivity (Figure
4b). The pattern of immunostaining for parvalbumin was
similar to that reported in previous studies [31,32,62], with
scattered cell bodies and a plexus of dendrites and axons
located on either side of the lamina II/III border. One
hundred and twenty eight parvalbumin-immunoreactive
cells (35-47 per rat) were identified in these sections.
These were found in lamina II (mainly IIi) and lamina III.
None of the galanin-immunoreactive cells was labelled by
the parvalbumin antibody and vice versa (Figures 2, 3).
The pattern of nNOS immunostaining was very similar to
that of nNOS-immunoreactivity or NADPH diaphorase
activity that has been reported in previous studies
[32-34,63]. Many nNOS-immunoreactive cells were seen
in lamina II, with a lower density in laminae I and III.
These were far more numerous than either the galanin or
parvalbumin cells, and therefore their locations were not
included in Figure. 2. None of the parvalbumin cells, and
none of the galanin cells in laminae I or II, were nNOS-
immunoreactive (Figures 2, 3). However, 10 of the 12 gala-
nin cells in lamina III were positive for nNOS (Figures 2,
4).
In the sections reacted to reveal galanin and NPY, the
distribution of NPY staining was as described previously
[35,64,65], with a dense axonal plexus in laminae I-II
and scattered immunoreactive cells throughout laminae
I-III. We identified 199 galanin-immunoreactive cells
(52-86 per rat) and 251 NPY-immunoreactive cells (75-
97 per rat) in these sections, and all of these were
NeuN-positive, confirming that they were neurons.
Within this sample, 1 cell (corresponding to 0.5% of the
galanin population and 0.4% of the NPY population)
located in lamina II showed both types of immunoreac-
tivity, while all of the remaining cells were only labelled
with antibodies against one of the peptides (Figure 5).
Only 2 of the 300 NPY-immunoreactive boutons that
had been selected (100 each from 3 rats) were galanin-
immunoreactive.
Two hundred and twenty four NPY-immunoreactive
cells (71-80 per rat) were found in the sections that had
been reacted to reveal NPY and nNOS. Of these, 222
(99%) were not nNOS-immunoreactive, while two cells
(one in lamina I and one in lamina II) were double-
labelled. An example of a NPY cell that was negative for
nNOS is illustrated in Figure 6.
Figure 1 Galanin immunoreactivity in laminae I-III. A confocal image taken from a transverse section of the L3 segment that had been
reacted to reveal galanin. The solid line represents the outer limit of the grey matter, and the dashed lines show the borders between laminae I,
II and III. There is a dense plexus of immunoreactive axons in lamina I and the outer part of lamina II, with some staining in deeper parts of the
dorsal horn. Scattered immunoreactive cell bodies are visible, and three of these are marked with arrows. The insets show the two regions
outlined by boxes in the main figure, and have been enlarged to show the immunoreactive cell bodies more clearly. The image is a projection
of 6 optical sections at 1 μm z-spacing. Scale bar = 100 μm.
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The penetration of galanin immunostaining was appar-
ently complete in the sections that had been reacted
with anti-galanin, NeuN antibody and Sytox, since gala-
nin-immunoreactive cell bodies were seen at approxi-
mately equal frequency throughout the depths of the
sections. All of the galanin cells were NeuN-positive,
but most neurons in each lamina were not galanin-
immunoreactive (Figure 7). Quantitative analysis with
the disector method revealed that galanin-immunoreac-
tive neurons constituted 6.6, 3.1 and 2% of all of the
neurons in laminae I, II and III, respectively (Table 2).
Since galanin-containing cells are more densely packed
in the outer part of lamina II than in its inner part (Fig-
ure 2), we estimated the percentage of neurons in the
two halves of the lamina that were galanin-immunoreac-
tive, by drawing a line midway between its dorsal and
ventral borders. The proportion of neurons in lamina
IIo that were galanin-immunoreactive was 5%, while the
corresponding value for lamina IIi was 0.4% (Table 2).
Proportion of GABAergic boutons in laminae I-III that
contain galanin
When the sections reacted with antibodies against gala-
nin, CGRP and VGAT were scanned at high magnifica-
tion each type of immunostaining was found in
numerous small structures that presumably corre-
sponded to axonal boutons, while galanin was also seen
in cell bodies. CGRP-immunoreactive axons were parti-
cularly numerous in laminae I and IIo, but were also
found in laminae IIi and III. As reported previously [35],
VGAT-immunoreactive boutons were seen at high den-
sity throughout laminae I-III. There was no co-localisa-
tion of CGRP and VGAT.
Figure 2 The distribution of cells that were galanin or
parvalbumin immunoreactive in sections reacted to reveal
galanin, parvalbumin and nNOS. The diagram shows the laminar
location of all of the cells that were galanin (blue) or parvalbumin
(red) immunoreactive in the 6 sections that were analysed (2 each
from 3 rats). For the galanin cells, those that were also nNOS
immunoreactive are shown as filled circles, while those that lacked
nNOS are open circles. None of the parvalbumin cells contained
nNOS, and there was no colocalisation of galanin and parvalbumin.
Figure 3 Lack of co-localisation of galanin, nNOS and parvalbumin in lamina II. a Confocal image showing part of lamina II that has been
scanned to reveal galanin (Gal, red). Two galanin-containing cell bodies are visible (arrowheads). b, c The same field scanned for nNOS (green)
and parvalbumin (PV, blue). In each case, immunoreactive cell bodies can be seen. d The merged image shows the lack of co-localisation of the
three types of immunoreactivity in the cell bodies. The images were obtained from a single optical section. Scale bar = 20 μm.
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immunoreactive. Many CGRP boutons were also posi-
tive for galanin, although CGRP boutons that lacked
galanin were also present. Galanin-immunoreactivity
was seen in some of the VGAT-positive boutons (Figure
8). The percentages of VGAT boutons in laminae I, II
and III that were galanin-immunoreactive were 6.2, 3.3
and 0.7, respectively (Table 3). When lamina II was sub-
divided into outer and inner halves, the percentages in
these were 5.7 and 1.1. The mean of the z-axis lengths
for the galanin-positive boutons was 1.14 μm (n = 61),
w h i l et h ec o r r e s p o n d i n gv a l u ef o rt h eV G A Tb o u t o n s
that lacked galanin was 1.21 μm (n = 1739), and these
did not differ significantly (p = 0.09, Mann-Whitney U
test). This means that it is unlikely that our sample was
biased towards either galanin-positive or galanin-nega-
tive boutons among the VGAT population.
Discussion
The main findings of this study are: (1) that galanin,
which has previously been shown to be expressed only
by GABAergic interneurons [26], is present in a differ-
ent population from those that contain NPY, parvalbu-
min or nNOS in laminae I-II, although it is co-
expressed with nNOS in some lamina III cells, and (2)
that the galanin cells constitute around 7% of all of the
neurons in lamina I and ~3% of those in lamina II.
Since all NPY cells [28,35], and many of those that
Figure 4 Co-localisation of galanin and nNOS in a lamina III neuron. a Confocal image shows a lamina III neuron that is immunoreactive for
nNOS (green). b The same field scanned for galanin (Gal, magenta) shows that the same cell is weakly immunoreactive. c A merged image. The
images are from three optical sections at 2 μm z-spacing. Scale bar = 20 μm.
Figure 5 Lack of co-localisation of galanin and NPY. a, b, c show a confocal image from laminae I-IIo scanned for galanin (Gal, red), NPY
(green) and the neuronal marker NeuN (blue), respectively. d A merged image. One of the NeuN-positive cell bodies is galanin-immuno-reactive
(arrow) and another is NPY-immunoreactive (arrowhead). The image is a projection of 3 optical sections at 1 μm z-separation. Scale bar = 20 μm.
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GABAergic, this indicates that these four compounds
can be used to define neurochemically distinct popula-
tions of inhibitory interneurons in the superficial dorsal
horn.
Lack of co-localisation of galanin with NPY, nNOS or
parvalbumin
Our finding that NPY and galanin show minimal co-
existence in neurons in laminae I-III differs from that of
Zhang et al. [61], who reported that some galanin-
immunoreactive neurons were also NPY-immunoreac-
tive, although they did not determine the frequency of
double-labelled cells. We did identify a single lamina II
neuron that showed both types of immunoreactivity, but
this corresponded to less than 1% of each population,
and was therefore an extremely rare event. A significant
difference between the experimental protocols of these
two studies is that Zhang et al. had applied colchicine to
block axoplasmic transport of the peptide from cell
bodies. While this increases the sensitivity for detecting
peptidergic neurons, it may have direct effects on neuro-
peptide expression. For example, Cortes et al. [66]
reported a dramatic increase in the levels of galanin
mRNA in several brain regions after intracerebroventri-
cular administration of colchicine. This could have
resulted from up-regulation by cells that normally
expressed the peptide, but may also have involved de
novo synthesis [66]. It is likely that upregulation of gala-
nin or NPY in the superficial dorsal horn following
Figure 6 Lack of co-localisation of NPY and nNOS. A single confocal optical section through lamina II, scanned to reveal: a NPY (green) and
b nNOS (magenta). A merged image is shown in c. This field contains cell bodies that are immunoreactive for NPY (arrowhead) or nNOS, but
the two types of immunoreactivity are not co-localised. Scale bar = 20 μm.
Figure 7 Staining for galanin, NeuN and Sytox in a section used for stereological analysis. a A single confocal optical section through
laminae I and II scanned to reveal galanin (Gal, red). b The same field scanned for NeuN (blue), and the nuclear stain Sytox (green). c A merged
image. Neuronal nuclei can be recognised by the presence of both NeuN and Sytox staining, and therefore appear cyan, while non-neuronal
nuclei are green. Two of the neurons (arrowheads) are immunoreactive for galanin. This appears in a ring surrounding the nucleus,
corresponding to the perikaryal cytoplasm. Scale bar = 20 μm.
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Page 8 of 13colchicine treatment explains the difference between our
results and those of Zhang et al. [61]. It is quite possible
that there are neurons in this region that are NPY- or
galanin-immunoreactive and also express the other pep-
tide, but at levels that are below our detection threshold.
However, even if this is the case, the lack of co-localisa-
tion of the two types of immunoreactivity in our experi-
m e n t sp r o v i d e sau s e f u lw a yo fd i s t i n g u i s h i n gt w o
distinct and largely non-overlapping neuronal popula-
tions. Using immunogold labelling at the ultrastructural
level, Zhang et al. [61] reported occasional co-localisa-
tion of galanin and NPY in nerve profiles (presumed
axon terminals) in untreated rats. However, in a pre-
vious study they had shown co-localisation of galanin,
NPY and CGRP [39], and since CGRP is thought to be
present exclusively in primary afferent terminals in the
dorsal horn, the axons that were labelled for both NPY
and galanin are likely to have been primary afferent
axons. The almost complete lack of coexistence of NPY
and galanin that we found in axonal boutons in laminae
I-III further supports the suggestion that the two
peptides are present in largely non-overlapping neuronal
populations.
The lack of overlap between galanin and parvalbumin
populations is consistent with their different locations,
since galanin cells are concentrated in laminae I and IIo,
while the parvalbumin cells are mainly in lamina IIi and
III (Figure 2). We are not aware of any previous studies
that have compared the expression of nNOS and galanin
among dorsal horn interneurons. However, the lack of
co-localisation in laminae I-II is not surprising, because
it has been reported that most NADPH diaphorase-posi-
tive (nNOS-containing) GABAergic neurons in this
region are also enriched with glycine [33], whereas gala-
nin is restricted to those GABAergic neurons that are
not glycine-enriched [26]. The presence of nNOS in
most of the few galanin neurons that were seen in
lamina III suggests that these represent a small but dis-
tinctive population of inhibitory interneurons.
Laing et al. [32] reported that NADPH diaphorase
activity was not co-localised with either NPY or parval-
bumin, and the present results confirm that nNOS is
Table 2 Percentages of neurons in laminae I-III that were galanin immunoreactive
Number of
neurons counted
galanin-
immunoreactive
cells
% of neurons that were
galanin-immunoreactive
% of neurons that are
GABA-immunoreactive*
Estimated % of GABA neurons
that contain galanin
I 91.3 (80 - 97) 6 (5 - 8) 6.6 (5.2 - 8.2) 24.8 26.4
II 200 (175 - 220) 6 (4 - 8) 3.1 (1.8 - 4.6) 31.3 9.9
IIo 116.7 (99-127) 5.7 (4-7) 5 (3.2-7.1)
IIi 83.3 (76-96) 0.3 (0-1) 0.4 (0-1.3)
III 131.7 (104-155) 2.7 (1 - 5) 2 (0.7 - 3.2) 40.2 4.9
In each case the mean values for the 3 animals are shown, with the range in brackets. * The percentages of neurons in each lamina that are GABA-
immunoreactive are taken from the data for the L4-5 segmental levels of 3 naïve Sprague-Dawley rats examined by Polgár et al. [1].
Figure 8 Co-localisation of galanin with CGRP and VGAT. a, b, c A confocal image through part of lamina II scanned for galanin (Gal, green),
CGRP (red) and VGAT (blue), respectively. d A merged image. The small immunoreactive structures correspond to axonal boutons. Several Gal
immunoreactive profiles can be seen and most of these are also labelled with the CGRP antibody (two indicated with arrowheads). These appear
yellow in d. Two of the galanin-positive boutons (arrows) are also immunostained for VGAT. The image was obtained from 2 optical sections at
0.3 μm z-separation. Scale bar = 5 μm.
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Page 9 of 13not expressed at detectable levels in neurons that con-
tain either of these compounds. We have previously
reported that NPY and parvalbumin do not co-exist in
neurons in laminae I-III [32].
Sub-populations of inhibitory interneurons
The results of the present study show that in the rat L3
segment, galanin-containing cells constitute around
6.6%, 3.1% and 2% of the total neuronal population in
lamina I, II and III, respectively. All of these cells are
thought to be GABAergic [26], and we have previously
reported that 24.8%, 31.3% and 40.2% of neurons in
laminae I, II and III at the L4-5 level are GABA-immu-
noreactive in Sprague-Dawley rats [1]. If we assume that
similar proportions of neurons are GABAergic in the L3
segment in Wistar rats, we can estimate the proportion
of GABAergic neurons that are galanin-immunoreactive
as ~26%, 10% and 5% for lamina I, II and III (Table 2).
In a recent study, we quantified NPY-immunoreactive
cells (which are also all GABA-immunoreactive [28]) in
the L4 segment of Wistar rats and estimated that these
account for 23% of the GABAergic neurons in lamina I,
17% of those in lamina II and 9% of those in lamina III.
This suggests that cells that contain either galanin or
NPY make up around half of the GABAergic neurons in
lamina I and a quarter of those in lamina II.
Galanin-containing axons in the dorsal horn are
derived from at least two sources: primary afferents and
intrinsic dorsal horn neurons [61]. As reported pre-
viously [38,39], we found extensive coexistence of gala-
nin and CGRP, which is present in most (if not all)
peptidergic primary afferents [67]. Galanin was also
found to be co-localised with VGAT, which is restricted
to axonal boutons that use GABA and/or glycine as a
neurotransmitter [49,50]. The galanin/VGAT-positive
profiles are presumably axonal boutons derived from the
local galanin interneurons. However, the peptide was
only found in around 6% of the VGAT-positive boutons
in lamina I and 3% of those in lamina II, even though
we estimate that 26% of the GABAergic neurons in
lamina I and 10% of those in lamina II contain galanin.
One possible explanation for this discrepancy is that a
substantial part of the total population of GABAergic
boutons in this region does not originate from local
neurons, and that this component lacks galanin. Consis-
tent with this, it has been shown that there is a signifi-
cant descending GABAergic input to the superficial
dorsal horn that originates from the caudal ventromedial
medulla [68], an area that contains very low levels of
g a l a n i nm R N A[ 6 6 ] .H o w e v e r ,t h ep r o p o r t i o no f
GABAergic boutons that are derived from extrinsic
sources is not yet known. Another possibility is that the
level of expression of galanin is very low in the axons of
some cells that contain the peptide at detectable levels
in their cell bodies. However, this seems unlikely, as
peptide concentrations are generally considerably higher
in axonal boutons than in the perikaryal cytoplasm [66].
The most likely explanation is that the galanin cells gen-
erate relatively small axonal arbors, and are therefore
under-represented among the GABAergic boutons in
the superficial dorsal horn. In order to test this, it will
be necessary to record from and label individual gala-
nin-containing interneurons, and then examine the
extent of their axonal arborisations.
Functions of galanin-containing neurons
Galanin released by these cells can act on receptors that
are expressed by local dorsal horn neurons and by the
central terminals of primary afferents. mRNAs for all 3
of the galanin receptors (GalR1-3) have been identified
in primary afferents in the dorsal root ganglia, while
that for GalR1 is also highly expressed by dorsal horn
neurons [69-72]. Galanin acting at spinal levels appears
to exert both anti-nociceptive and pro-nociceptive
actions, and these are thought to be mediated by GalR1
and GalR2, respectively [73,74]. It has also been sug-
gested that galanin may have neuroprotective and devel-
opmental roles mediated by GalR2 [75]. However, the
amount of galanin in axons of dorsal horn neurons
appears to be lower than that in primary afferents, since
dorsal rhizotomy causes a substantial depletion of gala-
nin-immunoreactivity in the superficial laminae
[38,57,76]. Therefore release of galanin from intrinsic
neurons may be relatively modest, compared to the
amount that can be released from primary afferents.
At present, there is little information about the pri-
mary afferent input to different types of inhibitory inter-
neuron in the superficial dorsal horn, although it is
likely that the galanin-containing cells are innervated by
nociceptive afferents since these terminate extensively in
laminae I-IIo, where most of the galanin cells are
located. Consistent with this suggestion, we have
recently found that after injection of capsaicin into the
rat hindpaw, ~40% of the galanin-immunoreactive
Table 3 Percentages of VGAT boutons in laminae I-III
that were galanin-immunoreactive
Lamina VGAT boutons analysed % VGAT boutons Gal+
I 600 (100) 6.2 (4 - 8.5)
II 600 (100) 3.3 (3 - 4)
IIo 303 (98-103) 5.7 (4.1 - 7.1)
IIi 297 (97-102) 1.1 (0 - 2.2)
III 600 (100) 0.7 (0 - 1.5)
The second column shows the total number of VGAT boutons from each
lamina (or sublamina) that were analysed, with the range per animal (n = 3
rats) shown in brackets. The mean percentages of the VGAT-positive boutons
that were galanin-immunoreactive are shown in the third column, with ranges
per animal in brackets.
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Page 10 of 13neurons in the medial part of the ipsilateral dorsal horn
contain phosphorylated extracellular signal regulated
kinases (pERK), whereas this was seen in very few of the
nNOS-immunoreactive cells (~2%) and in none of those
that contained parvalbumin (S. Tiong, E. Polgár and A.J.
Todd, unpublished data). Since pERK is a marker of
neuronal activation [77], it is likely that many of the
galanin-containing inhibitory interneurons in laminae I-
IIo respond to noxious stimulation. This suggests that
among the functions that have been proposed for inhibi-
tory interneurons [7], the galanin cells are more likely to
have a role in regulating the level of activity of other
neurons (including projection cells) in response to nox-
ious stimuli, than in blocking spontaneous activity of
projection cells or minimising cross-talk between sen-
sory modalities and preventing tactile allodynia [3,4].
Conclusions
Laing et al. [32] reported that expression of NPY, nNOS
and parvalbumin could be used to identify three differ-
ent populations of GABAergic interneurons in laminae
I-III. The results of the present study show that immu-
nostaining for galanin defines a fourth neurochemical
population of inhibitory interneurons in this region.
Most of the galanin-containing cells were located in
laminae I-IIo, where they accounted for 5-7% of all neu-
rons, with only a small number being present in laminae
IIi-III. Based on the results of a previous quantitative
analysis of GABA-immunoreactivity [1], we estimate
that the galanin cells constitute around 26%, 10% and
5% of the GABAergic interneurons in laminae I, II and
III, respectively. However, only ~6% of GABAergic bou-
tons in laminae I-IIo and ~1% of those in IIi-III were
galanin-immunoreactive. A possible explanation for this
discrepancy is that the galanin cells generate smaller
axonal arbors than other GABAergic interneurons in
this region.
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